Drugs / CVD 909
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00326443 | Feb 2006 → Sep 2007 | typhoid fever | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CVD 909 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00326443 ↗ |
| Modality | Vaccine | “S. Typhi vaccine strain CVD 909” NCT00326443 ↗ |
| Route | Oral | “5 X 10\^9 CFU of oral S. Typhi vaccine strain CVD 909 with buffer administered on Day 0.” NCT00326443 ↗ |